Table 1 Key results from an analysis assessing costs and cost effectiveness of expanding malaria community case management to all ages in Farafangana, Madagascar from November 2019 to December 2021
Indicator | Mean | Range (95% CI) |
|---|---|---|
Annual health facility consultations averted | 200,275.1 | [135,703.7, 285,122.9] |
Annual hospitalizations averted | 1699.2 | [171.0, 6993.9] |
Deaths averted per year | 99.6 | [60.9, 154.6] |
Additional cases seen annually per CHW | 294.3 | [199.8–419.7] |
Incremental CHW* hours per year | 110.5 | [72.0, 157.4] |
Startup costs | $63,210.2 | [$50,270.9, $77,918.8] |
Admissions costs averted | $180,637.9 | [$17,792.6, $756,770.1] |
Clinic costs averted | $696,546.5 | [$472,720.4, $990,598.4] |
DALYs averted# | 3,721.7 | [2,054.2, 4,863.1] |
Productivity benefits | $178,907.97 | [$98,213.00, $305,963.64] |
Caretaker benefits | $328,908.15 | [$247,732.54, $439,707.53] |
Averted deaths benefits (elasticity 1.4) | $344,014.63 | [$210,648.39, $534,195.37] |
Inpatient daily hotel costs | $6.51 | [$4.75, $8.55] |
CE$ threshold | $132.92 | [$25.60, $690.2] |
ICER^ health system | -$21.86 | [-$136.93, $95.63] |
ICER^ societal perspective (no deaths) | –$135.64 | [-$1,918.45, 35.89] |
ICER^ societal perspective (with deaths) | -$243.29 | [-$2,056.15, -$49.31] |